Background: SERPINE1, also known as plasminogen activator inhibitor (PAI), has been proposed as a potential blood biomarker for the early detection and diagnosis of Alzheimer’s disease (AD). Here, SERPINE1 is linked to early-onset autosomal dominant Alzheimer disease.